Bologna
Italy
72
2022-08-04
The entities that hold a legal rights for patent applications filed by inventor Viscomi Giuseppe Claudio:
Giuseppe Claudio Viscomi from Bologna, IT has applied for patents for these inventions. The list has both pending applications and granted patents:
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL CONTAINING XYLOGLUCAN AND ALCOHOLS FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
#2 | 2022-04-28POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#3 | 2022-04-21PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#4 | 2021-08-12PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#5 | 2020-10-29PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#6 | 2020-10-29POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#7 | 2020-01-30for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof
#8 | 2020-01-02GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN
#9 | 2019-12-26NSAID ADMINISTRATION AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#10 | 2019-10-17Oral compositions for the treatment of gastroesophageal reflux
#11 | 2019-08-29PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#12 | 2019-08-29POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#13 | 2019-05-09POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#14 | 2019-05-09PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#15 | 2019-01-31Methods of treating symptoms of gastroparesis using velusetrag
#16 | 2018-12-13Solvated crystal form of rifaximin, production, compositions and uses thereof
#17 | 2018-03-08PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#18 | 2018-03-08POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#19 | 2017-09-14Therapeutic and nutritional compositions for functional gastrointestinal disorders
#20 | 2017-07-27POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#21 | 2017-07-27PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#22 | 2017-07-06PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHODS AND USE THEREOF
#23 | 2017-04-13Use of polyols to obtain stable polymorphous forms of rifaximin
#24 | 2017-03-30Solvated crystal form of rifaximin, production, compositions and uses thereof
#25 | 2017-03-16PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#26 | 2016-11-03Forms of rifaximin and uses thereof
#27 | 2016-09-08Rifaximin derivative and uses thereof
#28 | 2016-02-18METHOD FOR DIAGNOSING VAGINAL INFECTIONS
#29 | 2016-02-11RIFAXIMIN FOR USE IN THE TREATING OF VAGINAL INFECTIONS
#30 | 2015-12-03Rifaximin derivative and uses thereof
#31 | 2015-10-22Forms of rifaximin and uses thereof
#32 | 2015-07-02PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#33 | 2015-06-25POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#34 | 2015-03-19PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#35 | 2015-03-12USE OF POLYOLS TO OBTAIN STABLE POLYMORPHOUS FORMS OF RIFAXMIN
#36 | 2014-12-25Rifaximin derivative and uses thereof
#37 | 2014-10-16NSAID ADMINISTRATION AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#38 | 2014-08-21Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
#39 | 2014-07-03GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN
#40 | 2014-04-24Gastroresistant pharmaceutical formulations containing rifaximin
#41 | 2014-03-20Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof
#42 | 2014-01-09Forms of rifaximin and uses thereof
#43 | 2013-10-31Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
#44 | 2013-10-31Rifamycin derivatives
#45 | 2013-10-24Polymorphic forms α, β and γ of rifaximin
#46 | 2013-07-18MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FORMULATIONS
#47 | 2013-03-21Use of polyols to obtain stable polymorphous forms of rifaximin
#48 | 2013-02-21Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
#49 | 2013-01-31Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
#50 | 2013-01-03Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
#51 | 2012-10-11RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#52 | 2012-09-27PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#53 | 2012-09-20COMPOSITIONS COMPRISING NONSTEROIDAL ANTI - INFLAMMATORY DRUGS
#54 | 2012-08-23PROCESSES FOR THE PRODUCTION OF POLYMORPHIC FORMS OF RIFAXIMIN
#55 | 2012-08-09POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#56 | 2012-08-09PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#57 | 2012-04-12MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONS
#58 | 2012-03-08Use of polymorphic forms of rifaximin for medical preparations
#59 | 2012-02-09RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#60 | 2011-06-30Processes for the production of polymorphic forms of rifaximin
#61 | 2011-06-30Polymorphic forms α, β and γ of rifaximin
#62 | 2011-06-23Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
#63 | 2011-04-14RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#64 | 2010-12-30Gastroresistant Pharmaceutical Formulations Containing Rifaximin
#65 | 2010-10-21Rifamycin derivatives
#66 | 2010-01-14Use of polyols to obtain stable polymorphous forms of rifaximin
#67 | 2009-03-26Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
#68 | 2009-01-08Gastroresistant pharmaceutical formulations containing rifaximin
#69 | 2008-10-23Processes for the production of polymorphic forms of rifaximin
#70 | 2008-10-23Polymorphic forms α, β and γ of rifaximin
#71 | 2008-10-23RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#72 | 2008-10-23Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
10862 ⎘